The first ThreatsDay Bulletin of 2026 tracks GhostAd adware, macOS malware, proxy botnets, cloud exploits, and more emerging ...

Modalis Therapeutics Corporation (TOKYO: 4883) today announced that its research article titled “Efficient LAMA1 gene activation by epigenome editing as a therapeutic approach for LAMA2-CMD” has been ...